China's Brain-Computer Interface Race Hits Clinic
China's BCI industry is moving from lab to operating table, led by Shanghai's cluster, a world-first implant approval and a fast-rising funding boom.
Tag
7 articles
China's BCI industry is moving from lab to operating table, led by Shanghai's cluster, a world-first implant approval and a fast-rising funding boom.
China's brain-computer interface sector hits clinical milestones, from the first approved invasive BCI to a surge in financing and investment.
China's NMPA released YY/T 2029-2026, the world's first BCI medical device standard covering AI-processed EEG datasets, effective September 2027.
China's NMPA published YY/T 2029-2026, the world's first standard for BCI medical devices using AI to process EEG data, effective Sept 2027.
China's BCI sector sees explosive growth: 70B yuan in H1 2026 investment, first approved invasive device, and a decade of policy backing.
China leads two new international biomaterials standards for surgical implants, shifting from industry follower to global rule-maker.
China renews coronary stent procurement with 4,468 hospitals, expanding access to life-saving cardiac care at reduced prices.